Hemogenyx Pharmaceuticals PLC Announces Director/PDMR Shareholding

By: Hemogenyx Pharmaceuticals PLC via AccessWire

May 30, 2022 at 02:00 AM EDT

LONDON, UK / ACCESSWIRE / May 30, 2022 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has been notified that Andrew Wright, the Company's Financial Controller and Company Secretary (PDMR), has purchased 1,284,889 ordinary shares of £0.01 each in the Company ("Ordinary Shares") at a price of 1.44p per share. Following this transaction, Mr Wright has a total beneficial interest in 4,000,000 Ordinary Shares, representing approximately 0.41 per cent of the Company's issued share capital.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

1.	Details of PDMR/person closely associated with them ("PCA")
a)	Name	Andrew Wright
2.	Reason for the notification
a)	Position/status	Financial Controller and Company Secretary
b)	Initial notification/ amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Full name of the entity	Hemogenyx Pharmaceuticals plc
b)	Legal Entity Identifier code	2138008L93GYU5GN6179
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of Hemogenyx Pharmaceuticals plc GB00BYX3WZ24
b)	Nature of the transaction	Standalone acquisition of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) GBP £0.0144 1,284,889
d)	Aggregated information - Aggregated volume - Price	Price(s) Volume(s) GBP £18,502.40 1,284,889
e)	Date of the transaction	2022-05-27
f)	Place of the transaction	London Stock Exchange XLON

Enquiries:

Hemogenyx Pharmaceuticals plc	https://hemogenyx.com
Dr Vladislav Sandler, Chief Executive Officer & Co-Founder	headquarters@hemogenyx.com
Peter Redmond, Director	peter.redmond@hemogenyx.com

SP Angel Corporate Finance LLP	Tel: +44 (0)20 3470 0470
Matthew Johnson, Vadim Alexandre, Adam Cowl

Peterhouse Capital Limited	Tel: +44 (0)20 7469 0930
Lucy Williams, Duncan Vasey, Charles Goodfellow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Hemogenyx Pharmaceuticals PLC

View source version on accesswire.com:
https://www.accesswire.com/703196/Hemogenyx-Pharmaceuticals-PLC-Announces-DirectorPDMR-Shareholding

Hemogenyx Pharmaceuticals PLC Announces Director/PDMR Shareholding

More News

Recent Quotes